Copper Tripeptide-1 cosmetic platform
GHK-Cu Copper Peptide Microneedle Patch OEM
A premium copper peptide dissolving microneedle patch concept for renewal, firming-care and targeted appearance programs, subject to oxidation and matrix-compatibility validation.
AI-generated product & process concepts. Final specifications are project-dependent.
Product architecture
Ingredient-led cosmetic microneedle patch concept
| Formula direction | Copper Tripeptide-1 (GHK-Cu) with a controlled dissolving matrix; HA or selected complementary cosmetic peptides may be screened. |
|---|---|
| Application formats | Under-eye crescents, forehead patches, smile-line pairs, localized recovery-care patches and premium multi-use kits. |
| Development focus | Copper-peptide identity, color specification, oxidation control, assay, moisture protection and compatibility with other formula components. |
| Claim boundary | Keep claims cosmetic and appearance based. Do not describe the patch as wound treatment, post-procedure medical care or a substitute for a medical procedure. |
OEM and private-label options
Formula
Review peptide identity, supplier form, target content, matrix polymers and compatible supporting cosmetic ingredients.
Patch geometry
Choose forehead, smile-line, under-eye, spot or other application-area shapes with an appropriate array footprint.
Packaging
Develop moisture-protective sachets, trays, cartons, display boxes or premium kits for the intended channel.
What must be verified before scale-up
- Exact ingredient identity, purity, supplier carrier and target-market status.
- Compatibility with pH, water activity, polymers and the selected drying process.
- Needle-tip formation, mechanical integrity, dissolution and content uniformity.
- Finished-product stability in the final tray, sachet and secondary packaging.
- Consumer safety, instructions and substantiation for the final cosmetic claims.
Technical resource: Copper Tripeptide-1 development guide.
Scope: This is an OEM development concept, not a finished-product efficacy promise. Formula, concentration, safety, claims and market status are confirmed for each project.